As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...